Skip to Content
Merck
CN

Key Documents

View All Documentation

09293

2-(3-Aminopropylamino)ethanol

≥98.0% (GC)

Synonym(s):

N-(2-Hydroxyethyl)trimethylenediamine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
NH2CH2CH2CH2NHCH2CH2OH
CAS Number:
4461-39-6
Molecular Weight:
118.18
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
329748756
EC Number:
224-718-0
Beilstein/REAXYS Number:
1734412
MDL number:
MFCD00025617
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

assay

≥98.0% (GC)

refractive index

n20/D 1.486

bp

250-252 °C (lit.)

density

1.007 g/mL at 20 °C (lit.)

SMILES string

NCCCNCCO

InChI

1S/C5H14N2O/c6-2-1-3-7-4-5-8/h7-8H,1-6H2

InChI key

GHKSKVKCKMGRDU-UHFFFAOYSA-N

Gene Information

rat ... Grin2a(24409)

Other Notes

Inhibitor of the mammalian glycogen debranching enzyme; Photographic development accelerator.

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

hcodes

H314,H317

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - Skin Sens. 1

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

296.6 °F

flash_point_c

147 °C

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme.
B K Gillard et al.
Biochemistry, 16(18), 3978-3987 (1977-09-06)
Panagiotis Mastorakos et al.
Journal of controlled release : official journal of the Controlled Release Society, 262, 37-46 (2017-07-12)
The discovery of powerful genetic targets has spurred clinical development of gene therapy approaches to treat patients with malignant brain tumors. However, lack of success in the clinic has been attributed to the inability of conventional gene vectors to achieve
Stephany Y Tzeng et al.
International journal of nanomedicine, 6, 3309-3322 (2012-01-10)
Biodegradable poly(ester amine) (PEA)-based and poly(amido amine) (PAA)-based nanoparticles were developed for efficient in vitro siRNA delivery to human umbilical vein endothelial cells (HUVECs). They were screened, characterized, and compared with traditionally studied DNA-containing particles. Several of the polymeric nanoparticles
View All Related Papers